Page last updated: 2024-08-21

ethyl pyruvate and Lymphoma, Large B-Cell, Diffuse

ethyl pyruvate has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gribben, JG; Guan, XW; Jia, L; Liu, FT; Zhang, T1

Other Studies

1 other study(ies) available for ethyl pyruvate and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
    Cell death & disease, 2019, 04-15, Volume: 10, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Female; G1 Phase Cell Cycle Checkpoints; HMGB1 Protein; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-akt; Pyruvates; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor

2019